GenAI scaling 3x faster than past tech waves - research (AIQ:NASDAQ)
GenAI revenue is tripling past prior IT waves, set to top $100B by year three.
YayaNews contributes financial news and market context through the YayaNews editorial workflow.

GenAI revenue is tripling past prior IT waves, set to top $100B by year three.
GenAI scaling 3x faster than past tech waves - research (AIQ:NASDAQ) | Seeking Alpha
Copy Link
Save
Play
(
<1min
)
Comments
Vertigo3d/iStock via Getty Images
The generative artificial intelligence (
AIQ
) (
AIEQ
) industry is scaling its revenue at an unprecedented rateâgrowing three times faster than any previous major IT wave, according to new research from Exponential View.
The estimate is based on realized revenue trajectories adjusted
To ensure this doesnât happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please
report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.
Search field
Entering text into the input field will update the search result below
Entering text into the input field will update the search result below
Recommended For You
More
Trending News
See More
»
Original YayaNews editorial coverage, published for informational purposes.
This article is sourced from Seeking Alpha. It is for informational purposes only and does not constitute investment advice.
Topics & Symbols
Continue Reading
Related Reading
Saudi Arabia resumes oil loadings at its biggest export terminal after four-month halt
Saudi Arabia has resumed oil loadings at the Ras Tanura terminal on the Persian Gulf after a nearly four-month halt due to the closing of the Strait of Hormuz.

Bitwise Ethereum Option Income Strategy ETF declares $0.097 dividend (NYSEARCA:IETH)
Bitwise Ethereum Option Income Strategy ETF (IETH) declares $0.097/share monthly dividend (7.26% forward yield).

BTC Digital announces private placement financing of up to $28M (BTCT:NASDAQ)
BTC Digital (BTCT) prices $7M share offering at $1.14 with warrants; deal closes June 29, 2026.

Avalo Therapeutics to join Russell 2000, 3000 indexes (AVTX:NASDAQ)
Avalo Therapeutics (AVTX) joins the Russell 2000 & Russell 3000 effective June 26, 2026.
